The efficacy and safety of animal-derived nootropics in cognitive disorders: Systematic review and meta-analysis
Background: The animal-derived nootropics, Cerebrolysin, Actovegin and Cortexin, may have potential in treating neurocognitive disorders. Although these drugs have international usage, reports on their efficacy have been conflicting. These agents have been suggested for all dementia types, but may h...
Main Authors: | Rayan A. Alsulaimani, Terence J. Quinn |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Cerebral Circulation - Cognition and Behavior |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266624502100009X |
Similar Items
-
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design
by: Alla Guekht, et al.
Published: (2013-12-01) -
Nootropic and Adaptogenic Effect of Combined Use of Cortexin with Polyunsaturated Fatty Acids Concentrate under Experimental Dislipidemia
by: Tatyana I. Sangadieva, et al.
Published: (2019-04-01) -
Advances in neurometabolic therapy
by: V. V. Zakharov, et al.
Published: (2019-11-01) -
Efficacy of complex treatment of glaucoma optical neuropathy by Cortexin
by: Shcherbinina I.V., et al.
Published: (2010-12-01) -
TREATMENT OF COGNITIVE IMPAIRMENT AFTER STROKE
by: V. V. Zakharov, et al.
Published: (2018-02-01)